An Act to Prohibit Discrimination in Access to Anatomical Donations and Organ Transplants
LD 1055 would create a new state law prohibiting disability-based discrimination in access to anatomical gifts and organ transplants. It defines key terms such as “qualified recipient,” “auxiliary aid or service,” and “organ transplant,” and bars health care facilities and providers from treating a person as ineligible for transplantation, denying transplant-related services, refusing referrals, or placing a person lower on a waiting list solely because of disability. The bill also requires providers to make reasonable modifications to policies and procedures, and to take reasonable steps to ensure access to transplant-related services when auxiliary aids or services are needed, unless doing so would fundamentally alter the service or create an undue burden.
The bill further limits when a disability may be considered medically significant: providers may consider disability only after an individualized evaluation and only to the extent it is medically relevant to the transplant decision. It also states that a person’s inability to independently comply with post-transplant requirements cannot be treated as medically significant if the person has a support system to help meet those requirements. The bill expressly preserves existing federal ADA remedies and does not create a right to compensatory or punitive damages, but it does allow an affected individual to seek injunctive or equitable relief in Superior Court.
In addition to regulating health care facilities and providers, LD 1055 would apply to health insurance carriers that offer coverage for anatomical gifts, organ transplants, or related services. Those carriers could not deny, limit, or penalize coverage solely because of a covered individual’s disability, and they could not reduce coverage to avoid the bill’s requirements. However, the bill does not require insurers to cover organ donation or transplant services if they do not already do so.
The overall sentiment reflected by the bill text is strongly supportive of disability rights and equal access to medically necessary transplant services. The measure is framed as an anti-discrimination and access bill, with no recorded committee debate or votes in the provided materials to indicate opposition or amendment activity. Its structure suggests an intent to align transplant access practices with broader civil rights protections while preserving clinical judgment for medically inappropriate transplants.
The main point of potential contention is the balance between anti-discrimination protections and provider discretion. Health care facilities and insurers may be concerned about the scope of required accommodations, the individualized assessment standard, and the possibility of civil litigation for injunctive relief. Disability advocates, by contrast, would likely support the bill’s limits on categorical exclusions and its requirement that support networks and reasonable modifications be considered before denying access.
LD 1055 would add a new disability nondiscrimination framework for organ donation and transplant access in Maine law, affecting health care facilities, transplant providers, and health insurance carriers. It would prohibit categorical denial of transplant-related services based solely on disability, require reasonable modifications and auxiliary aids, and create a private right of action for injunctive or equitable relief. It would also constrain how insurers may use disability in coverage decisions for transplant-related care, while leaving existing federal ADA protections and medically inappropriate clinical decisions intact.
The bill appears to have a generally favorable, rights-protective orientation, with its text emphasizing equal access, reasonable accommodations, and protection from disability-based exclusion in transplant settings. No committee transcript or vote record was provided, so there is no documented legislative debate to suggest organized opposition or support beyond the bill’s stated purpose. Based on the language alone, the measure is framed as a civil rights and health access bill rather than a controversial policy expansion.
The likely areas of contention are the extent of required accommodations, the limits on provider discretion, and the potential for litigation. Health care facilities and providers may object to being required to modify policies or consider support networks in transplant eligibility decisions, while insurers may be concerned about coverage mandates and administrative burden. Supporters would likely argue that the bill prevents unjust exclusion of people with disabilities and ensures decisions are based on individualized medical assessment rather than stereotypes or assumptions.